SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
CELC

Celcuity Inc. (CELC)

United States · Delayed Price · Currency is USD
Services-Medical Laboratories
66.88+1.63 (+2.50%)
 
Insider Score
––Not scored
CELC Insider Score

Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

CELC analyst forecast

CELC analyst consensus

Moderate Buy6 ratings
Buy 6 Hold 0 Sell 0

Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.

CELC 12-month price target

$140.00+110.3% upsideaverage of 1 firm
$140.00High
$140.00Low

Best analysts covering CELC

  • Needham76%success rate · 21 calls
  • HC Wainwright & Co.67%success rate · 9 calls
  • Stifel67%success rate · 3 calls
  • Craig-Hallum0%success rate · 1 call

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

CELC analyst ratings

FirmPrice targetAction
Cantor Fitzgerald—$140.00+127.4%—2026-10-22
—TD CowenBuy——Reiterated2026-10-21
—NeedhamBuy——Reiterated2026-09-30
—GuggenheimBuy——Reiterated2026-08-17
—CitizensMarket Outperform——Reiterated2026-08-17
—NeedhamBuy——Reiterated2026-08-14
—StifelBuy——Reiterated2026-08-14
—HC Wainwright & Co.Buy——Reiterated2026-08-14
—CitizensMarket Outperform——Reiterated2026-07-15
—HC Wainwright & Co.Buy——Reiterated2026-07-15
—HC Wainwright & Co.Buy——Reiterated2026-06-03
—Wells FargoOverweight——Reiterated2026-06-03
—Craig-HallumBuy——Reiterated2026-06-03
—HC Wainwright & Co.Buy——Reiterated2026-05-18
—Wells FargoOverweight——Reiterated2026-05-15
—NeedhamBuy——Reiterated2026-05-15
—NeedhamBuy——Reiterated2026-05-04
—CitizensMarket Outperform——Reiterated2026-05-04
—GuggenheimBuy——Reiterated2026-05-04
—HC Wainwright & Co.Buy——Upgraded2026-05-04
—NeedhamBuy——Reiterated2026-03-26
—StifelBuy——Reiterated2026-03-26
—NeedhamBuy——Reiterated2026-03-17
—NeedhamBuy——Reiterated2026-03-10
—JefferiesBuy——Reiterated2025-12-02
—HC Wainwright & Co.Neutral——Downgraded2025-11-17
—Craig-HallumBuy——Reiterated2025-11-13
—StifelBuy——Reiterated2025-11-13
—HC Wainwright & Co.Buy——Reiterated2025-10-22
—NeedhamBuy——Reiterated2025-10-20
—NeedhamBuy——Reiterated2025-10-03
—HC Wainwright & Co.Buy——Reiterated2025-08-18
—NeedhamBuy——Reiterated2025-08-15
—NeedhamBuy——Reiterated2025-07-28
—HC Wainwright & Co.Buy——Reiterated2025-07-28
—Leerink PartnersOutperform——Reiterated2025-07-28
—NeedhamBuy——Reiterated2025-06-30
—HC Wainwright & Co.Buy——Reiterated2025-05-19
—NeedhamBuy——Reiterated2025-05-15
—NeedhamBuy——Reiterated2025-04-11
—HC Wainwright & Co.Buy——Reiterated2025-04-01
—NeedhamBuy——Reiterated2025-04-01
—NeedhamBuy——Reiterated2025-02-06
—HC Wainwright & Co.Buy——Reiterated2024-11-15
—NeedhamBuy——Reiterated2024-11-15
—StifelBuy——Reiterated2024-10-07
—StifelBuy——Reiterated2024-08-15
—NeedhamBuy——Reiterated2024-08-15
—HC Wainwright & Co.Buy——Reiterated2024-08-15
—NeedhamBuy——Reiterated2024-05-31
—StifelBuy——Reiterated2024-05-16
—HC Wainwright & Co.Buy——Reiterated2024-05-16
—NeedhamBuy——Reiterated2024-05-16
—NeedhamBuy——Reiterated2024-04-12
—Craig-HallumBuy——Reiterated2024-03-28
—HC Wainwright & Co.Buy——Reiterated2024-03-28
—NeedhamBuy——Reiterated2024-03-28
—NeedhamBuy——Reiterated2023-11-13
—NeedhamBuy——Reiterated2023-09-22
—NeedhamBuy——Reiterated2023-08-11

CELC earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2026-03-25-1.06-0.97$1.3M$0
2026-05-14-1.04-0.97$2.9M$0
2026-08-13-1.16-1.44$4.4M$0
2026-11-11-1.500.00$1.6M$0
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.